C3 and C4 are the two most abundant proteins in the complement system, a network of blood proteins that helps your immune system fight infections and clean up damaged cells. Doctors order C3 and C4 blood tests primarily to check whether your immune system is overactive, underactive, or consuming these proteins faster than your body can replace them. The results help diagnose and monitor conditions ranging from lupus to hereditary angioedema to severe infections, though interpreting them is rarely straightforward because many different processes can push the numbers up or down at the same time.
What C3 and C4 Do in Your Body
The complement system is one of the oldest parts of human immunity. It consists of roughly 30 proteins circulating in the blood, most of them inactive until triggered. When something trips the system, a cascade of protein-splitting reactions unfolds, ultimately punching holes in bacteria, flagging debris for cleanup, and calling in white blood cells. C3 and C4 sit at critical junctures in this cascade.1PubMed. The role of the complement system in innate immunity
C4 acts early. When the immune system detects antibodies stuck to a pathogen or recognizes certain sugar patterns on a microbe’s surface, C4 gets cleaved into fragments. One of those fragments, C4b, physically attaches to the target’s surface and serves as a landing pad for assembling the enzyme complexes that chew through C3.2The Journal of Immunology. Structural Basis for the Function of Complement Component C4 within the Classical and Lectin Pathways of Complement C3 is the convergence point: nearly every complement activation route eventually splits C3 into pieces. Those pieces coat invaders (making them easier for immune cells to eat), recruit inflammatory cells to the site, and feed into the final steps that build membrane attack complexes capable of killing bacteria directly.
Because C3 and C4 are consumed during these reactions, their blood levels drop when the complement system is heavily activated. And because the liver produces both proteins as part of the body’s general inflammatory response, their levels can also rise during infection or tissue injury. This dual behavior is exactly why a doctor might order the test and exactly why the results need careful context.
Low Levels and Autoimmune Disease
The single most common reason doctors check C3 and C4 is to evaluate autoimmune disease, especially systemic lupus erythematosus (SLE). In lupus, the immune system generates antibodies against the body’s own tissues, and those antibodies form immune complexes that activate complement relentlessly. The complement system burns through C3 and C4 trying to clear these complexes, so blood levels of both proteins drop. Tracking complement levels helps doctors gauge how active the disease is, assess the risk of organ damage, and judge whether treatment is working.3PubMed Central. Complement as a Biomarker for Systemic Lupus Erythematosus
The relationship between complement and lupus kidney disease is especially well studied. Research on lupus patients has found that those with persistently low or fluctuating complement levels are more likely to develop kidney involvement, along with blood count abnormalities like low white cell or platelet counts.4RMD Open. Complement levels and risk of organ involvement in patients with systemic lupus erythematosus In predicting lupus kidney flares specifically, the two proteins behave a bit differently: falling C4 levels tend to forecast an upcoming flare, while falling C3 levels tend to accompany one that’s already underway.5PubMed Central. The complex nature of serum C3 and C4 as biomarkers of lupus renal flare That distinction matters clinically, because catching a C4 drop early can prompt a doctor to intervene before kidney damage escalates.
An even more specific pattern has been described: when C3 falls much lower than C4, it may signal that the alternative complement pathway (a different activation route that bypasses C4 entirely) has kicked in alongside the usual route. One study found this pattern almost exclusively in lupus patients with active kidney disease, suggesting it’s a red flag for renal involvement.6International Urology and Nephrology. The significance of C3 and C4 complement levels in lupus nephritis
Lupus is not the only autoimmune condition that consumes complement. Low C3 and C4 have been documented in cryoglobulinemia associated with Sjögren syndrome, where abnormal antibodies clump together in cold temperatures and deposit in small blood vessels, triggering complement activation. In one reported case, a patient with Sjögren syndrome and kidney inflammation had strikingly low complement levels, with C4 nearly undetectable.7American Journal of Kidney Diseases. Sjögren Syndrome and Cryoglobulinemic Glomerulonephritis
High Levels and the Acute-Phase Response
While low complement often signals autoimmune consumption, high complement tells a different story. C3 and C4 are acute-phase proteins, meaning the liver ramps up their production in response to inflammation, infection, or tissue injury. During an acute infection, C3 and C4 can climb as much as 50 percent above baseline.8Annals of the Rheumatic Diseases. ELEVATED SERUM COMPLEMENT (C3/C4) LEVEL AS AN INFLAMMATORY MARKER FOR INFECTION IN PATIENTS WITH FEVER: A RETROSPECTIVE STUDY This rise is the body’s way of restocking the ammunition the immune system uses to fight off invaders.
One practical wrinkle: C3 and C4 are sluggish acute-phase proteins compared to markers like C-reactive protein (CRP). While CRP can spike within hours of an insult, measurable increases in C3 and C4 take several days to show up on blood work.9PubMed Central. Reference distributions for complement proteins C3 and C4: a practical, simple and clinically relevant approach in a large cohort That delay means a complement test drawn early in an infection might still look normal even though the system is fully engaged.
This was observed during the COVID-19 pandemic, when researchers found elevated C3, C4, and overall complement activity in hospitalized patients, reflecting the intense inflammatory response the virus triggers.10PubMed Central. Elevated levels of C3, C4, and CH50 of the complement system in ICU and non-ICU patients with COVID-19 In that setting, high complement was not reassuring. It was a marker of how hard the body was fighting.
Why Infections Can Push Levels in Either Direction
This is the part that trips people up: infections can cause C3 and C4 to go up or down depending on the balance between production and consumption. If the liver’s output of new complement outpaces how fast the immune system chews through it, levels rise. If consumption outstrips production, levels fall. Both can be happening simultaneously, and the number your lab report shows is just the net result.
In severe bacterial bloodstream infections, for instance, low C3 and C4 have been associated with worse outcomes. Patients with Gram-negative bacteremia who had depleted C4 and C3 were more likely to develop septic shock and die within 30 days.11PubMed Central. Complement levels in patients with bloodstream infection due to Staphylococcus aureus or Gram-negative bacteria In those cases, the complement system was being overwhelmed by the infection, consuming proteins faster than the body could replace them.
A study on infective endocarditis (infection of the heart valves) added another layer of complexity. Even though complement activation products were clearly elevated, the actual levels of C3 and C4 stayed within the normal range. The researchers concluded that C3 and C4 concentration alone is not a reliable indicator of whether complement is actively being consumed.12PubMed Central. Complement activation in infective endocarditis: correlation with extracardiac manifestations and prognosis The reason is straightforward: new production can mask consumption. This is why, in research settings and some specialty clinics, doctors may order more sensitive tests that measure complement split products rather than the parent proteins.
Screening for Hereditary Angioedema
Low C4 serves as a screening tool for a very different condition: hereditary angioedema (HAE). HAE causes unpredictable episodes of severe swelling in the face, throat, hands, feet, or abdomen. It results from a deficiency or malfunction of a protein called C1-inhibitor, which normally keeps early complement activation in check. Without that brake, the system chews through C4 continuously, and C4 levels stay chronically low even between attacks.13PubMed Central. Diagnosis and screening of patients with hereditary angioedema in primary care
Because C4 is inexpensive and widely available, it’s often the first test ordered when a doctor suspects HAE. But there’s a catch. About one in five untreated HAE patients can have normal C4 levels on a given blood draw. One study found the sensitivity of low C4 for diagnosing HAE was 81 percent, meaning it missed roughly a fifth of confirmed cases. Genetic testing in those missed patients still showed mutations in the C1-inhibitor gene.14Clinical and Experimental Immunology. An evaluation of tests used for the diagnosis and monitoring of C1 inhibitor deficiency: normal serum C4 does not exclude hereditary angio-oedema The practical takeaway: if a doctor strongly suspects HAE based on symptoms, they should order C1-inhibitor testing regardless of what C4 shows.15PubMed. Complement factor C4 activation in patients with hereditary angioedema
Genetic Complement Deficiencies
Some people are born with very low or absent levels of C3 or C4 due to inherited deficiencies. These are rare but medically significant. People lacking C4 are prone to both recurrent infections and autoimmune disorders, a seeming paradox that reflects complement’s dual role in fighting pathogens and cleaning up the immune complexes that drive autoimmunity.16PubMed Central. Complement C4, Infections, and Autoimmune Diseases Complete C3 deficiency is even rarer and tends to cause severe, life-threatening bacterial infections starting in early childhood.
Beyond C3 and C4, inherited defects elsewhere in the complement system can cause a range of problems including kidney disorders like atypical hemolytic uremic syndrome, age-related macular degeneration, and the swelling episodes of HAE described above.17PubMed Central. European Society for Immunodeficiencies (ESID) and European Reference Network on Rare Primary Immunodeficiency, Autoinflammatory and Autoimmune Diseases (ERN RITA) Complement Guideline: Deficiencies, Diagnosis, and Management When a child or young adult presents with unusually severe or recurrent infections, or with lupus-like symptoms at an early age, checking complement levels is a standard part of the workup. A consistently undetectable C3 or C4 on repeated testing, rather than a single low reading, points toward a genetic cause.
The Liver Connection
Your liver produces the vast majority of circulating C3 and C4. This means liver disease can independently lower complement levels, and interpreting a low result requires knowing whether the liver is healthy enough to make these proteins in the first place.
In chronic hepatitis C, C3 tends to track the liver’s functional reserve. Early in the disease, C3 can actually be elevated because inflammation drives production. But as fibrosis progresses to cirrhosis and functional liver tissue is replaced by scar tissue, the hepatocytes responsible for churning out C3 dwindle, and serum C3 drops accordingly.18Annals of Clinical & Laboratory Science. Complement Component 3 as a Surrogate Hallmark for Metabolic Abnormalities in Patients with Chronic Hepatitis C In severe cirrhosis, low complement can be a sign of liver failure rather than immune activation, and mistaking one for the other could send a clinical investigation down the wrong path.
Autoimmune liver diseases present yet another pattern. In conditions like autoimmune hepatitis, primary biliary cholangitis, and primary sclerosing cholangitis, C3 and C4 levels tend to run higher than in healthy individuals, likely reflecting the chronic inflammatory drive that pushes the liver to overproduce acute-phase proteins.19PubMed. The role of complement activation in autoimmune liver disease This is the opposite of what many people expect from an autoimmune disease and illustrates why context is everything when reading complement results.
Complement Levels During Pregnancy
Pregnancy normally raises C3 and C4 levels. Two separate studies confirmed that both proteins increase gradually throughout gestation, with values rising steadily from the first trimester through delivery.20PubMed Central. Normal range of complement components during pregnancy: A prospective study21PubMed Central. Variation of Complement Protein Levels in Maternal Plasma and Umbilical Cord Blood during Normal Pregnancy: An Observational Study This matters clinically because a pregnant woman with lupus might have complement levels that look “normal” on paper but are actually low relative to where they should be at her stage of pregnancy. Without pregnancy-specific reference ranges, a lupus flare could be missed.
Kidney Biopsy and Complement Staining
Beyond blood levels, complement testing sometimes involves looking directly at tissue. In kidney biopsies, pathologists stain for complement components deposited in the glomeruli, the kidney’s tiny filtering units. The pattern of complement deposition helps distinguish between different types of kidney disease.
One example: when doctors need to tell post-infectious glomerulonephritis (kidney inflammation following a strep or staph infection) apart from C3 glomerulopathy (a rare condition driven by uncontrolled complement activation), they can stain for a fragment called C4d. In one study, most post-infectious cases showed moderate C4d staining, while only a minority of C3 glomerulopathy cases did.22PubMed Central. C4d at Crossroads Between Post-Infectious Glomerulonephritis and C3 Glomerulopathy The distinction matters because the two conditions have very different prognoses and treatment approaches.
How Sample Handling Affects Results
Complement proteins are sensitive to how blood samples are collected, stored, and processed. If the sample sits too long at room temperature or is thawed improperly, complement can activate inside the tube, giving artificially low readings for intact proteins and artificially high readings for activation fragments.
The good news for routine C3 and C4 testing is that these proteins are relatively sturdy. A study comparing samples stored at refrigerator temperature versus deep freeze found nearly perfect agreement in measured C3 and C4 levels, with no clinically meaningful difference between the two conditions.23PubMed. The Effect of different storage temperatures on complement protein (C3 and C4) levels: A single-centre study The more sensitive complement activation markers are a different story. For tests measuring split products like C3a or C4d, thawing samples at body temperature instead of on ice caused dramatic spikes in measured levels, and the type of collection tube mattered: EDTA tubes protected against artificial activation better than standard serum tubes.24American Journal of Clinical Pathology. Effect of Blood Sampling, Processing, and Storage on the Measurement of Complement Activation Biomarkers
For you as a patient, this is mostly invisible. But if your complement results seem inconsistent with your symptoms and your doctor is puzzled, improper sample handling is one of the mundane explanations worth considering before assuming the biology has changed.
Complement-Targeted Therapies and Monitoring
A relatively new reason your doctor might order complement testing is to monitor treatment with complement-inhibiting drugs. Medications like eculizumab and ravulizumab block complement component C5, downstream of both C3 and C4, and are used to treat conditions like paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome. As these therapies become more common, labs are increasingly asked to measure complement activity to confirm the drug is adequately blocking the cascade in a given patient. The testing requirements here are more complex than a simple C3 and C4 level, often involving functional assays that measure the system’s overall killing power rather than just protein concentrations.
Newer drugs targeting C3 itself are also in clinical use or late-stage development for conditions like geographic atrophy (a form of macular degeneration) and C3 glomerulopathy. As the menu of complement-targeted treatments expands, monitoring C3 and C4 levels takes on a pharmacological dimension it did not have a decade ago.
Why Interpretation Is Harder Than It Looks
The fundamental challenge with C3 and C4 testing is that the numbers you see on a lab report represent a snapshot of a moving target. Multiple forces are pulling in opposite directions simultaneously: inflammation drives production up, immune complex formation drives consumption down, liver function sets the ceiling on output, and genetic variation determines each person’s baseline. A reading that falls within the lab’s printed “normal range” might still be abnormally low for you if your personal baseline runs high, or it might mask active complement consumption that is being offset by acute-phase production.9PubMed Central. Reference distributions for complement proteins C3 and C4: a practical, simple and clinically relevant approach in a large cohort
This is why serial measurements over time tend to be more informative than any single value. A steadily dropping C4 in someone with lupus tells a clearer story than one low reading on a random Tuesday. And combining complement levels with other markers, such as anti-double-stranded DNA antibodies, erythrocyte sedimentation rate, or urinalysis, produces a far more complete picture than complement alone. No single blood test operates in isolation, but C3 and C4 are especially context-dependent, which is both their limitation and the reason they remain so widely ordered.